A prospective study on emergence of mucormycosis in recently recovered COVID-19 patients
dc.contributor.author | Landge, S. | en_US |
dc.contributor.author | Menon, S. | en_US |
dc.contributor.author | Chande, C. | en_US |
dc.contributor.author | Kulkarni, M. | en_US |
dc.contributor.author | Bhilkar, K. | en_US |
dc.contributor.author | Bade, J. | en_US |
dc.contributor.author | Joshi, A. | en_US |
dc.date.accessioned | 2024-09-24T10:51:30Z | |
dc.date.available | 2024-09-24T10:51:30Z | |
dc.date.issued | 2023-07 | |
dc.description.abstract | Background: Mucormycosis is an angio-invasive fungal infection with high morbidity and mortality. This infection seems to be increasing during the second wave of COVID-19. Objectives of this study were to identify and characterise the fungal species causing post-covid-mycosis, to analyze the cases for underlying co-morbidities if any and to correlate the associated risk factors with the progression of disease. Methods: Prospective observational study which constituted conventional fungal culture of 188 tissue specimens collected from clinically suspected mucormycosis patients who had history of COVID. Results: This study noted the occurrence of disease with predominance of males (72.03%). Most common symptoms were facial/periorbital swelling, followed by facial pain and headache. Among co-morbid conditions, diabetes mellitus was the most common (71.17%). Use of steroids (65.25%), antivirals therapy (22.86%), oxygen support (11.86%) used in management of COVID patients were found to be risk factors in post-covid-mucormycosis. radiological diagnosis showed involvement of paranasal sinuses (77.11%), followed by orbit (16.94%) and brain (5.90%). Mucor spp. was isolated in 21 cases. Although commonest fungus isolated was Aspergillus, analysis of the data for last 5 years showed a significant rise of Mucormycosis cases. Mortality was seen in 17.79% cases. Conclusions: Fungal aetiology should be kept in mind in patients with above clinical presentations with history of recent COVID-19 infection especially who received steroids. | en_US |
dc.identifier.affiliations | Department of Microbiology, Grant Government Medical College and Sir J.J. Group of Hospitals, Mumbai, Maharashtra, India | en_US |
dc.identifier.affiliations | Department of Microbiology, Grant Government Medical College and Sir J.J. Group of Hospitals, Mumbai, Maharashtra, India | en_US |
dc.identifier.affiliations | Department of Microbiology, Grant Government Medical College and Sir J.J. Group of Hospitals, Mumbai, Maharashtra, India | en_US |
dc.identifier.affiliations | Department of Microbiology, Grant Government Medical College and Sir J.J. Group of Hospitals, Mumbai, Maharashtra, India | en_US |
dc.identifier.affiliations | Department of Microbiology, Grant Government Medical College and Sir J.J. Group of Hospitals, Mumbai, Maharashtra, India | en_US |
dc.identifier.affiliations | Department of Microbiology, Grant Government Medical College and Sir J.J. Group of Hospitals, Mumbai, Maharashtra, India | en_US |
dc.identifier.affiliations | Department of Microbiology, Grant Government Medical College and Sir J.J. Group of Hospitals, Mumbai, Maharashtra, India | en_US |
dc.identifier.citation | Landge S., Menon S., Chande C., Kulkarni M., Bhilkar K., Bade J., Joshi A.. A prospective study on emergence of mucormycosis in recently recovered COVID-19 patients. International Journal of Research in Medical Sciences. 2023 Jul; 11(7): 2498-2502 | en_US |
dc.identifier.issn | 2320-6071 | |
dc.identifier.issn | 2320-6012 | |
dc.identifier.place | India | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/234467 | |
dc.language | en | en_US |
dc.publisher | Medip Academy | en_US |
dc.relation.issuenumber | 7 | en_US |
dc.relation.volume | 11 | en_US |
dc.source.uri | https://doi.org/10.18203/2320-6012.ijrms20232089 | en_US |
dc.subject | Aspergillosis | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Diabetes mellitus | en_US |
dc.subject | Post-covid-mucormycosis | en_US |
dc.subject | Steroid | en_US |
dc.title | A prospective study on emergence of mucormycosis in recently recovered COVID-19 patients | en_US |
dc.type | Journal Article | en_US |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- ijrms2023v11n7p2498.pdf
- Size:
- 146.6 KB
- Format:
- Adobe Portable Document Format